Liver Cancer Trial, Recruiting NCT06867172 Sponsor: Carol Davila University of Medicine and Pharmacy Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06867172
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have at least one cyst on the pancreas measuring 5mm or larger, identified through CT scan and internal ultrasound, OR people who are healthy with no pancreatic condition, OR people who have been diagnosed with pancreatic cancer confirmed by a tissue sample test

Who may not be able to join:

  • People who have not provided signed written consent to participate
  • People whose other health conditions make it unsafe for them to have an endoscopy (a procedure using a flexible camera tube)
  • People who have a metal stent (a small tube used to keep passages open) placed in the liver, bile duct, or pancreas area at the time of their initial CT scan
  • People who have inflammation of the pancreas (pancreatitis) at the time of their initial scan
  • People who have had pancreatic surgery performed at the trial department at the time of their initial scan
  • People who have had their spleen removed
  • People whose alcohol intake is above a certain level — more than 20g per day (or 140g per week) for men, or more than 10g per day (or 70g per week) for women (confirm with trial site for how this is measured)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mihai Ciocirlan, MD PhD, Romanian Society of Digestive Endoscopy

Phone: +40751015445

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Carol Davila University of Medicine and Pharmacy
Registry
ClinicalTrials.gov
Start date
1 January 2019
Est. completion
31 March 2025

Where this trial is recruiting

🇷🇴 Romania

Primary endpoints

increased prevalence of pancreatic steatosis in neoplastic cystic lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov